Myocardial Flow Reserve and Coronary Calcification in Prognosis of Patients With Suspected Coronary Artery Disease
Autor: | Jabir Farea, Ahmed Ibrahim Ahmed, Amjad M. Ahmed, Ahmed Alsaileek, Mohsen Alharthi, Ihab Suliman, Mouaz H. Al-Mallah, Dalia Ahmed, Ahmed Aljizeeri, Awadelkarim Elneama, Mousa Alfaris |
---|---|
Rok vydání: | 2021 |
Předmět: |
Male
medicine.medical_specialty Coronary Artery Disease 030204 cardiovascular system & hematology Coronary Angiography 030218 nuclear medicine & medical imaging Coronary artery disease 03 medical and health sciences Myocardial perfusion imaging 0302 clinical medicine Predictive Value of Tests Internal medicine medicine Clinical endpoint Humans Radiology Nuclear Medicine and imaging cardiovascular diseases Myocardial infarction Aged medicine.diagnostic_test business.industry Myocardial Perfusion Imaging Calcinosis Middle Aged Prognosis medicine.disease Coronary Calcium Score Positron emission tomography Cardiac PET Positron-Emission Tomography Cohort Cardiology Female Cardiology and Cardiovascular Medicine business |
Zdroj: | JACC: Cardiovascular Imaging. 14:2443-2452 |
ISSN: | 1936-878X |
DOI: | 10.1016/j.jcmg.2021.01.024 |
Popis: | The aim of this analysis is to examine the incremental prognostic value of coronary artery calcium (CAC) score and myocardial flow reserve (MFR) in patients with suspected coronary artery disease (CAD) undergoing positron emission tomography (PET) myocardial perfusion imaging (MPI).Advances in cardiac PET and computed tomography imaging enabled the simultaneous acquisition of anatomic and physiological data for patients suspected of CAD.Consecutive patients who underwent PET MPI and CAC score calculation at King Abdulaziz Cardiac Center, Riyadh, Saudi Arabia, between May 2011 and May 2018 were included in the study. MPI and CAC images were obtained in the same setting. The primary endpoint of the study was a composite of cardiac death and nonfatal myocardial infarction. Cox proportional hazard regression was used to assess the incremental prognostic value of CAC and MFR by sequentially adding the variables to a model that included clinical and PET variables.A total of 4,008 patients (mean age 59.7 ± 11.6 years, 55% women) were included in the analysis. Risk factors were prevalent (77.6% hypertension, 58.1% diabetes). In total, 35.9% of the cohort had CAC of 0, 16.5% had CAC ≥400, and 43.9% had MFR 2. Over a median follow up of 1.9 years, 130 (3.2%) patients had cardiac death/nonfatal myocardial infarction. CAC and MFR score added incremental prognostic value over clinical and perfusion variables (base model: c-index 0.8137; Akaike information criterion [AIC]: 1,865.877; p = 0.0011; CAC model: c-index = 0.8330; AIC: 1,850.810; p = 0.045 vs. base model; MFR model: c-index = 0.8279; AIC: 1,859.235; p = 0.024). Combining CAC and MFR did not enhance risk prediction (c-index = 0.8435; AIC: 1,846.334; p = 0.074 vs. MFR model; p = 0.21 vs. CAC model.) CONCLUSIONS: In this large cohort of patients referred for PET MPI, both CAC and MFR independently added incremental prognostic value over clinical and MPI variables. Although combining both may have synergetic prognostic effect, this relation was not shown in multivariable model of this analysis. |
Databáze: | OpenAIRE |
Externí odkaz: |